Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Yearbook of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0084-3873(10)79868-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

  2009cited by this paper

• Defining the Role of Postoperative Radio-Hormone Therapy in Prostate Cancer

  2025cites this paper
• The perks of combining extension and Gleason score of positive surgical margins after robot-assisted radical prostatectomy

  2025cites this paper
• Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomy

  2025cites this paper
• Biochemical Recurrence in Pathologic T3–4 Prostate Cancer: Indications for Adjuvant Radiotherapy

  2025cites this paper
• How to tailor the radiotherapy after radical prostatectomy in the modern era of molecular imaging, genomic testing, and technology development?

  2025cites this paper
• The p16 Immunostaining Predicts the Risk of Recurrence in Prostate Cancer

  2025cites this paper
• Prostate Cancer Radioligand Therapy: Beta-labeled Radiopharmaceuticals.

  2024cites this paper
• Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy

  2024cites this paper
• HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol

  2024cites this paper
• Intra-fractional geometric and dose/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy

  2024cites this paper
• VMAT in Prostate Cancer: Experience at the RABAT INO national Oncology Institute

  2024cites this paper
• Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer

  2024cites this paper
• Delayed definitive management of localized prostate cancer: what do we know?

  2024cites this paper
• Hot issues on Chinese expert consensus of prostate cancer management

  2024cites this paper
• Moderate hypofractionated radiotherapy to the prostate bed with or without pelvic lymph nodes: a prospective trial

  2024cites this paper
• Risk classification system using the detailed positive surgical margin status for predicting biochemical recurrence after robot‐assisted radical prostatectomy

  2024cites this paper
• Multimodality Therapies for Localized Prostate Cancer

  2023cites this paper
• Radiation after radical prostatectomy in elderly patients – a SEER database-derived competing-risk survival analysis of propensity score-matched age groups

  2023cites this paper
• The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy.

  2023cites this paper
• Adverse risk factors for salvage radiotherapy outcomes after radical prostatectomy in prostate cancer patients

  2023cites this paper
• ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.

  2023cites this paper
• OGT and FLAD1 Genes Had Significant Prognostic Roles in Progressive Pathogenesis in Prostate Cancer

  2023cites this paper
• Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer.

  2023cites this paper
• Utilizing clinical, pathological and radiological information to guide postoperative radiotherapy in prostate cancer

  2023cites this paper
• Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence

  2023cites this paper
• Evaluating the geometric and dosimetric impact of applying anisotropic CTV to PTV margins in image‐guided post‐prostatectomy radiation therapy

  2023influential citation
• Radiation therapy after radical surgery in prostate cancer

  2023cites this paper
• Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery

  2023cites this paper
• How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?

  2023cites this paper
• Oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer

  2023cites this paper
• Salvage Versus Adjuvant Radiation Therapy Following Radical Prostatectomy in Localised Prostate Cancer: A War Without a Winner

  2023cites this paper
• ERG Status at the Margin is Associated with Biochemical Recurrence after Radical Prostatectomy with Positive Surgical Margins.

  2023cites this paper
• Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome

  2023cites this paper
• Stereotactic body radiation therapy after radical prostatectomy: current status and future directions

  2023cites this paper
• Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma

  2023cites this paper
• Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy.

  2023cites this paper
• Salvage high-dose-rate interventional radiotherapy (brachytherapy) for locally relapsed prostate cancer after radical prostatectomy and subsequent external irradiation

  2023cites this paper
• Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review

  2022cites this paper
• Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: a cohort study with meta-analysis.

  2022cites this paper
• Management of patients with a persistently elevated PSA after radical prostatectomy: a narrative review

  2022cites this paper
• Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data

  2022influential citation
• Using PSMA imaging for prognostication in localized and advanced prostate cancer

  2022cites this paper
• Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

  2022cites this paper
• How can we best manage biochemical failure after radical prostatectomy?

  2022cites this paper
• Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives

  2022cites this paper
• Neoadjuvant 177Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial.

  2022cites this paper
• Radiation therapy post radical prostatectomy: who, when and why?

  2022cites this paper
• Targeted Chemoradiotherapy of Prostate Cancer Using Gold Nanoclusters with Protease Activatable Monomethyl Auristatin E.

  2022cites this paper
• World Clinical Oncology

  2022cites this paper
• Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography

  2022cites this paper
• Integration of magnetic resonance imaging into prostate cancer nomograms

  2022cites this paper
• The Effect of Adverse Surgical Margins on the Risk of Biochemical Recurrence after Robotic-Assisted Radical Prostatectomy

  2022cites this paper
• The impact of hegemonic masculine ideals on self‐esteem in prostate cancer patients undergoing androgen deprivation therapy (ADT) compared to ADT‐naïve patients

  2022cites this paper
• Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage

  2022cites this paper
• There is no doubt about the winner of the lion–rabbit fight

  2022cites this paper
• The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.

  2022cites this paper
• Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy

  2022cites this paper
• Radiotherapy after radical prostatectomy

  2022cites this paper
• Urologic Cancers

  2022influential citation
• Factors predicting biochemical recurrence following robot-assisted radical prostatectomy: single-center experience

  2022cites this paper
• Immediate or salvage radiotherapy after radical prostatectomy: Do we finally know?

  2022cites this paper
• Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy

  2022cites this paper
• [Assessment of positive surgical margins in the management of patients after radical prostatectomy for pT2 prostate cancer].

  2022cites this paper
• Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis

  2022cites this paper
• Narrative Review of the Post-Operative Management of Prostate Cancer Patients: Is It Really the End of Adjuvant Radiotherapy?

  2022influential citation
• Postoperative radiotherapy in prostate cancer: When and how? - An update review.

  2022cites this paper
• Nomograms for Metastasis-Free and Overall Survival for Pathologically Node Positive Prostate Cancer Patients Treated With or Without Radiation Therapy Plus Short-Term ADT.

  2022cites this paper
• EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis and local treatment with curative intent

  2022cites this paper
• Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data

  2022cites this paper
• Lower Bladder Toxicity of Salvage Versus Adjuvant Modern Radiotherapy for Prostate Cancer Patients

  2022cites this paper
• Twelve-year outcomes of prostate cancer after radical prostatectomy for T3 and/or positive margins managed with surveillance or salvage radiation therapy, based on risk groups

  2021cites this paper
• Prostate cancer

  2021cites this paper
• PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions

  2021cites this paper
• Long term outcomes between adjuvant radiotherapy and combined radiotherapy with hormonal treatment after radical prostatectomy in high risk prostate cancer

  2021cites this paper
• Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy

  2021cites this paper
• Machine learning algorithms can more efficiently predict biochemical recurrence after robot‐assisted radical prostatectomy

  2021cites this paper
• Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life

  2021cites this paper
• Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?

  2021cites this paper
• Clinical utility of subclassifying positive surgical margins at radical prostatectomy

  2021cites this paper
• Management of Recurrent Prostate Cancer After Radical Prostatectomy

  2021cites this paper
• Radiation treatment in prostate cancer: covering the waterfront

  2021cites this paper
• Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on.

  2021cites this paper
• Is hypofractionation acceptable for prostate bed radiotherapy?

  2021cites this paper
• Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation

  2021cites this paper
• Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer

  2021influential citation
• Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer.

  2021cites this paper
• Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death

  2021cites this paper
• Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point—a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)

  2021cites this paper
• Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries

  2021cites this paper
• Relative contribution of androgen deprivation therapy in combination with adjuvant radiotherapy for node-positive prostate cancer

  2021cites this paper
• Postoperative radiotherapy in prostate cancer - Authors' reply.

  2021cites this paper
• Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy

  2021cites this paper
• High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation

  2021cites this paper
• Adjuvant radiation for prostate cancer: too early to abandon?

  2021cites this paper
• Localized and Locally Advanced Prostate Cancer: Treatment Options

  2021cites this paper
• Performance Feedback May Not Improve Radical Prostatectomy Outcomes: The Surgical Report Card (SuRep) Study

  2021cites this paper
• Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomy

  2021cites this paper
• Management of Positive Surgical Margins After Radical Prostatectomy

  2021cites this paper
• Does post prostatectomy decipher score predict biochemical recurrence and impact care?

  2021cites this paper
• Re: Timing of Radiotherapy After Radical Prostatectomy (RadicalS-RT): A Randomised, Controlled Phase 3 Trial.

  2021cites this paper